129 related articles for article (PubMed ID: 2192846)
1. Lessons learned from molecular biology of insulin-gene mutations.
Steiner DF; Tager HS; Chan SJ; Nanjo K; Sanke T; Rubenstein AH
Diabetes Care; 1990 Jun; 13(6):600-9. PubMed ID: 2192846
[TBL] [Abstract][Full Text] [Related]
2. Hyperproinsulinemia in a three-generation Caucasian family due to mutant proinsulin (Arg65-His) not associated with imparied glucose tolerance: the contribution of mutant proinsulin to insulin bioactivity.
Röder ME; Vissing H; Nauck MA
J Clin Endocrinol Metab; 1996 Apr; 81(4):1634-40. PubMed ID: 8636380
[TBL] [Abstract][Full Text] [Related]
3. Lilly lecture 1983. Abnormal products of the human insulin gene.
Tager HS
Diabetes; 1984 Jul; 33(7):693-9. PubMed ID: 6376225
[TBL] [Abstract][Full Text] [Related]
4. A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).
Yano H; Kitano N; Morimoto M; Polonsky KS; Imura H; Seino Y
J Clin Invest; 1992 Jun; 89(6):1902-7. PubMed ID: 1601997
[TBL] [Abstract][Full Text] [Related]
5. Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by polymerase chain reaction.
Barbetti F; Raben N; Kadowaki T; Cama A; Accili D; Gabbay KH; Merenich JA; Taylor SI; Roth J
J Clin Endocrinol Metab; 1990 Jul; 71(1):164-9. PubMed ID: 2196279
[TBL] [Abstract][Full Text] [Related]
6. Insulin gene mutations and diabetes.
Nishi M; Nanjo K
J Diabetes Investig; 2011 Apr; 2(2):92-100. PubMed ID: 24843467
[TBL] [Abstract][Full Text] [Related]
7. INS-gene mutations: from genetics and beta cell biology to clinical disease.
Liu M; Sun J; Cui J; Chen W; Guo H; Barbetti F; Arvan P
Mol Aspects Med; 2015 Apr; 42():3-18. PubMed ID: 25542748
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin.
Groskreutz DJ; Sliwkowski MX; Gorman CM
J Biol Chem; 1994 Feb; 269(8):6241-5. PubMed ID: 8119968
[TBL] [Abstract][Full Text] [Related]
9. Familial hyperproinsulinemia associated with NIDDM. A case study.
Oohashi H; Ohgawara H; Nanjo K; Tasaka Y; Cao QP; Chan SJ; Rubenstein AH; Steiner DF; Omori Y
Diabetes Care; 1993 Oct; 16(10):1340-6. PubMed ID: 8269791
[TBL] [Abstract][Full Text] [Related]
10. Mutant insulin syndromes.
Vinik A; Bell G
Horm Metab Res; 1988 Jan; 20(1):1-10. PubMed ID: 3286444
[TBL] [Abstract][Full Text] [Related]
11. A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia.
Chan SJ; Seino S; Gruppuso PA; Schwartz R; Steiner DF
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2194-7. PubMed ID: 3470784
[TBL] [Abstract][Full Text] [Related]
12. [Etiology and molecular biology of hyperproinsulinemia].
Nakashima N; Umeda F
Nihon Rinsho; 1994 Oct; 52(10):2556-61. PubMed ID: 7983777
[TBL] [Abstract][Full Text] [Related]
13. Posttranslational cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia.
Shibasaki Y; Kawakami T; Kanazawa Y; Akanuma Y; Takaku F
J Clin Invest; 1985 Jul; 76(1):378-80. PubMed ID: 4019786
[TBL] [Abstract][Full Text] [Related]
14. Hyperproinsulinemia in a family with a proposed defect in conversion is linked to the insulin gene.
Elbein SC; Gruppuso P; Schwartz R; Skolnick M; Permutt MA
Diabetes; 1985 Aug; 34(8):821-4. PubMed ID: 2991050
[TBL] [Abstract][Full Text] [Related]
15. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin.
Gruppuso PA; Gorden P; Kahn CR; Cornblath M; Zeller WP; Schwartz R
N Engl J Med; 1984 Sep; 311(10):629-34. PubMed ID: 6382002
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and processing of genetically modified human proinsulin by rat myoblast primary cultures.
Simonson GD; Groskreutz DJ; Gorman CM; MacDonald MJ
Hum Gene Ther; 1996 Jan; 7(1):71-8. PubMed ID: 8825870
[TBL] [Abstract][Full Text] [Related]
17. Partial diversion of a mutant proinsulin (B10 aspartic acid) from the regulated to the constitutive secretory pathway in transfected AtT-20 cells.
Gross DJ; Halban PA; Kahn CR; Weir GC; Villa-Komaroff L
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4107-11. PubMed ID: 2657740
[TBL] [Abstract][Full Text] [Related]
18. Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
Robbins DC; Shoelson SE; Rubenstein AH; Tager HS
J Clin Invest; 1984 Mar; 73(3):714-9. PubMed ID: 6368587
[TBL] [Abstract][Full Text] [Related]
19. A novel point mutation in the insulin gene giving rise to hyperproinsulinemia.
Warren-Perry MG; Manley SE; Ostrega D; Polonsky K; Mussett S; Brown P; Turner RC
J Clin Endocrinol Metab; 1997 May; 82(5):1629-31. PubMed ID: 9141561
[TBL] [Abstract][Full Text] [Related]
20. Insulin delivery with plasmid DNA.
Abai AM; Hobart PM; Barnhart KM
Hum Gene Ther; 1999 Nov; 10(16):2637-49. PubMed ID: 10566891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
